Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2

Small trials have suggested that heterologous vaccination with first-dose ChAdOx1 and second-dose BNT162b2 may generate a better immune response than homologous vaccination with two doses of ChAdOx1. In this cohort analysis, we use linked data from Catalonia (Spain), where those aged <60 who rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermosilla, Eduardo, Coma, Ermengol, Xie, Junqing, Feng, Shuo, Cabezas, Carmen, Méndez-Boo, Leonardo, Fina, Francesc, Ballo, Elisabet, Martínez, Montserrat, Medina-Peralta, Manuel, Argimon, Josep Maria, Prieto-Alhambra, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943099/
https://www.ncbi.nlm.nih.gov/pubmed/35322045
http://dx.doi.org/10.1038/s41467-022-29301-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943099/
https://www.ncbi.nlm.nih.gov/pubmed/35322045
http://dx.doi.org/10.1038/s41467-022-29301-9

Ejemplares similares